A Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients with Thoracic Aortic Pathologies May 5, 2022 By Jesse Bufkin
Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Patients with Locally Advanced or Stage IV HER2 Positive Breast Cancer May 5, 2022 By Jesse Bufkin
A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma May 5, 2022 By Jesse Bufkin
Combined Targeted Therapies for Triple Negative Advanced Breast Cancer – A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib May 5, 2022 By Jesse Bufkin
SOUTH CAROLINA BLOODS: Epidemiology of Diabetes Interventions and Complications (EDIC) May 5, 2022 By Jesse Bufkin
Effect of Diesel Exhaust Particulate Exposure on Endothelial Function in Humans: The Role of Oxidative Stress May 5, 2022 By Jesse Bufkin
The Development of HER-2/neu (HER2) ICD Memory Immunity After Vaccination with a Plasmid Encoding HER2 ICD in Patients with Advanced Stage HER2 Overexpressing Breast and Ovarian Cancer May 5, 2022 By Jesse Bufkin
A study of the Virological and Immunological Events in Acute/Early HIV-1 Infection May 5, 2022 By Jesse Bufkin
Phase II study of myalgias/arthralgias associated with Letrozole (Femara): Role of serum letrozole levels and vitamin D deficiency May 5, 2022 By Jesse Bufkin
